Tsolaki, M., Tsantali, E., Lekka, Kiosseoglou, G., & Kazis, A. (2003). Can the Boston Naming Test be used as a clinical tool for differential diagnosis in dementia? Brain and Language, 87, 185-186. doi:10.1016/S0093-934X(03)00262-1

has been cited by the following article:

• TITLE: Boston Naming Test: Gender Differences in Older Adults with and without Alzheimer’s Dementia

  AUTHORS: James R. Hall, Hoa T. Vo, Leigh A. Johnson, April Wiechmann, Sid E. O’Bryant

  KEYWORDS: Boston Naming; Alzheimer’s Disease; Cardiovascular Risks; Gender

  JOURNAL NAME: Psychology, Vol.3 No.6, June 18, 2012

  ABSTRACT: The study clarifies the relationship between gender and performance on the BNT by controlling for the effects of demographic and health risk factors. Participants were 468 outpatient individuals (153 diagnosed with probable Alzheimer’s Disease (AD) and 318 cognitively intact) enrolled in the Texas Alzheimer’s Research and Care Consortium cohort. Participants under went evaluations including medical examination, interview, neuropsychological testing, and blood draw. The neuropsychological assessment consisted of the Wechsler Digit Span, Logical Memory, and Visual Reproduction, along with the Trail Making Test, Boston Naming Test (60-item version), verbal fluency (FAS), and the Geriatric Depression Scale (GDS-30).To control for severity of cognitive impairment only mild AD as shown by a CDR global score of 0.5 or 1.0 were used. Control males outperformed females (F = 10.81, p